(A) Schematic of Synthetic Notch Assay for Proteolytic Switches (SNAPS). Cells co-expressing Flag-Notch-X-Gal4 chimeras, where X is a putative proteolysis region of another receptor, and luciferase …
Luciferase reporter gene activity profile of Notch chimera constructs co-cultured with MS5 cells or MS5 cells stably transfected with DLL4, including treatment with BB-94 metalloprotease and GSI …
Cell surface ELISA performed with DMSO (negative control) or BB-94 (pan-metalloproteinase inhibitor). Data is normalized to the signal of DMSO condition. Error bars represent the SEM of triplicate …
Luciferase reporter gene activity profile of Notch in comparison to the Notch chimera constructs with SEA/SEA-like domains (A and C) or diverse receptors (B and D) co-cultured with MS5 cells or MS5 …
Luciferase reporter gene activity profile of Notch in comparison to the Notch chimera constructs plated in wells with no ligand or 20 μg/ml recombinant DLL4 ectodomain. Data shown are triplicate …
(A) Chimera constructs. Protein domains are color coded and labeled. (B) Luciferase reporter gene activity profile of Notch chimera constructs co-cultured with MS5 cells or MS5 cells stably …
(A) Chimera constructs used to test MMP sensitivity of Notch-Dag chimeras (B) Luciferase reporter gene activity of Notch-Dag chimeras containing intact proteolytic switch and truncated switch with …
(A) Chimera constructs for Notch and HER2 (human epidermal growth factor receptor 2. Protein domains are color coded and labeled. (B,C) SNAPS assay measuring effect of Herceptin on basal signaling …
(A) Scheme of Notch-E-cadherin (CADH1) chimera in which cadherin repeats 4 and 5 replace the Notch NRR. (B) SNAPS assay on Notch-CADH1 chimera (top) and a construct with 10 amino acids containing …
(A) EC50 calculation. The dose-dependent proteolytic activity enhancement of DECMA-1 was calculated by first subtracting the IgG control luciferase signal from the DECMA-1 signal at each …
Amino acid sequences for all proteolysis domains used in Notch-X chimeras.